Speech-Language Pathologists in Tuscaloosa, AL Accepting Medicare

46 Speech-Language Pathologists found. Showing 41 - 46

Amy Quitt, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 University Blvd E, Tuscaloosa, AL 35487 Phone: 205-348-1249    Fax: 205-348-7216

Mrs. Kandis Harris Chatman, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-348-7131    Fax: 205-348-1845

Mrs. Jennifer Baggett, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 603 Hackberry Lane, Tuscaloosa, AL 35401 Phone: 205-348-3130    Fax: 205-348-3157

Christopher Gaskill, PH.D Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 University Blvd East, Tuscaloosa, AL 35401 Phone: 205-348-7131    Fax: 205-348-1845

Mrs. Sara C. Shirley, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 700 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-349-7131    Fax: 205-348-1845

Johnna Bryant Springer, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1991 Idlewood Dr, Tuscaloosa, AL 35405 Phone: 205-389-0671

News Archive

Scientists develop new imaging technique to create three-dimensional images of melanoma

Melanoma is one of the less common types of skin cancer but it accounts for the majority of the skin cancer deaths (about 75 percent).The five-year survival rate for early stage melanoma is very high (98 percent), but the rate drops precipitously if the cancer is detected late or there is recurrence.So a great deal rides on the accuracy of the initial surgery, where the goal is to remove as little tissue as possible while obtaining "clean margins" all around the tumor.So far no imaging technique has been up to the task of defining the melanoma's boundaries accurately enough to guide surgery.Instead surgeons tend to cut well beyond the visible margins of the lesion in order to be certain they remove all the malignant tissue.Two scientists at Washington University in St. Louis have developed technologies that together promise to solve this difficult problem.

Baruch S. Blumberg Institute engaged to conduct study using ContraVir's new HBV therapeutic candidate

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.

New citizen science project aims to teach the public how to conduct climate research

A new citizen science project in Abisko in northern Sweden aims to teach the public how we do climate change science while collecting valuable data.

Study: Paradoxical adipose hyperplasia after cryolipolysis may not be a 'rare' complication

Cryolipolysis is a noninvasive cosmetic procedure that eliminates excess fat by freezing it. But a complication called paradoxical adipose hyperplasis -a hardened area of localized fat developing after cryolipolysis - may be more common than previously thought, suggests a paper in the July issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

FDA accepts Vanda Pharmaceuticals Iloperidone resubmission

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, reported today that the FDA has accepted Vanda's resubmission of the iloperidone New Drug Application (NDA).

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3(current)